(Q38051251)

27 August 2017

title

Idiopathic hypercalciuria and bone health (English)

1 reference

27 August 2017

Laura E Ryan

1

1 reference

27 August 2017

Steven W Ing

series ordinal

2

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current osteoporosis reports

27 August 2017

published in

1 reference

27 August 2017

volume

10

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

286-295

1 reference

The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Classification of idiopathic hypercalciuric patients by isotopic calcium absorption: a comparison with oral calcium tolerance test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Molecular mechanisms of primary hypercalciuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Familial idiopathic hypercalciuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Search for hidden secondary causes in postmenopausal women with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Creatinine excretion as a measure of protein nutrition in adults of varying age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Urinary Calcium Excretion in Human Beings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Increased intestinal vitamin D receptor in genetic hypercalciuric rats. A cause of intestinal calcium hyperabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3. A new characteristic of genetic hypercalciuric stone-forming rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Reduced vertebral bone density in hypercalciuric nephrolithiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Hypercalciuria and stones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Fasting and postprandial spot urine calcium-to-creatinine ratios do not detect hypercalciuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

RANKL is a mediator of bone resorption in idiopathic hypercalciuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Nephrolithiasis-associated bone disease: pathogenesis and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Bone alterations in patients with idiopathic hypercalciuria and calcium nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Fracture risk among patients with urolithiasis: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Factors associated with the lumbar spine and proximal femur bone mineral density in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Cloning and characterization of the human soluble adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Update on primary hypercalciuria from a genetic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

A randomized, double-masked, placebo-controlled trial of chlorthalidone and bone loss in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Thiazide diuretics affect osteocalcin production in human osteoblasts at the transcription level without affecting vitamin D3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Genetic hypercalciuric stone-forming rats have a primary decrease in BMD and strength

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stone-forming rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

Effect of aspirin and indomethacin on the serum and urinary calcium, magnesium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

A systematic review of omega-3 fatty acids and osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

A prospective study of thiazide use and fractures in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11914-012-0120-5

The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin

21 January 2018

1 reference

12 December 2020

Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria

1 reference

12 December 2020

Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures

1 reference

12 December 2020

Effect of Chlorothiazide and Hydrochlorothiazide on the Excretion of Calcium in Urine

1 reference

12 December 2020

Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism

1 reference

12 December 2020

Low bone mass in idiopathic renal stone formers: magnitude and significance

1 reference

12 December 2020

Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate

1 reference

12 December 2020

Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia

1 reference

12 December 2020

Urine calcium excretion predicts bone loss in idiopathic hypercalciuria

1 reference

12 December 2020

The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women

1 reference

12 December 2020

[Role of bones in the physiopathology of idiopathic hypercalciuria: effect of amino-bisphosphonate alendronate]

1 reference

12 December 2020

The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis.

1 reference

12 December 2020

Urinary calcium in perimenopausal women: normative values

1 reference

12 December 2020

About a primitive osseous origin of the so-called 'renal hypercalciuria'

1 reference

12 December 2020

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers

1 reference

12 December 2020

Use of random urine samples to estimate total urinary calcium and phosphate excretion

1 reference

12 December 2020

Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial

1 reference

12 December 2020

Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats

1 reference

12 December 2020

Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria

1 reference

12 December 2020

Idiopathic hypercalciuria: a preliminary report

1 reference

12 December 2020

10.1007/S11914-012-0120-5

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1053484940

0 references

1 reference